BACKGROUND: Myocardial injury after aneurysmal subarachnoid hemorrhage (aSAH) is associated with poor outcomes. Delayed cerebral ischemia (DCI) is also a complication of aSAH. We sought to determine whether (1) DCI could be predicted by demographics, aSAH severity/aneurysm location, or aSAH-associated myocardial injury (SAHMI), and (2) DCI is associated with increased mortality after aSAH. METHODS: Prospective longitudinal study of 149 aSAH subjects with definitive DCI evaluation, age 18-75 years, Hunt and Hess (HH) ≥ 3, and/or Fisher ≥ 2, and admitted to the Neurovascular ICU. DCI was defined by the presence of neurological deterioration accompanied by evidence of abnormal cerebral blood flow. RESULTS: Subjects were 48% DCI(+) and 52% DCI(-). DCI(+) subjects had more severe aSAH [HH (P = 0.002), Fisher (P = 0.004), admission Glasgow Coma Scale (P = 0.018)]. More DCI(+) subjects had pulmonary congestion than DCI(-) subjects (63 vs. 39%, P = 0.003). On echocardiogram, cardiac output (CO, liters per minute [LPM]) was significantly higher in DCI(+) than in DCI(-) subjects (6 ± 2 vs. 5 ± 1 LPM; P = 0.015). Multivariate analysis identified CO and Fisher grade as independent predictors of DCI (P = 0.02, 0.019). For each 1 LPM increase in CO, the odds of DCI increased by 1.5 (95% CI: 1.1-2.1). Fisher grade 4 increased the odds of DCI by 6.5 compared to Fisher grade 2 (95% CI: 1.6-25.8). After controlling for Fisher grade, CO remained an independent predictor of DCI (P = 0.02). Three-month mortality rate was not significantly different between DCI groups, P = 0.786. CONCLUSION: Elevated CO and Fisher grade are predictors of DCI after aSAH. However, prevention of DCI may not decrease mortality.
BACKGROUND:Myocardial injury after aneurysmal subarachnoid hemorrhage (aSAH) is associated with poor outcomes. Delayed cerebral ischemia (DCI) is also a complication of aSAH. We sought to determine whether (1) DCI could be predicted by demographics, aSAH severity/aneurysm location, or aSAH-associated myocardial injury (SAHMI), and (2) DCI is associated with increased mortality after aSAH. METHODS: Prospective longitudinal study of 149 aSAH subjects with definitive DCI evaluation, age 18-75 years, Hunt and Hess (HH) ≥ 3, and/or Fisher ≥ 2, and admitted to the Neurovascular ICU. DCI was defined by the presence of neurological deterioration accompanied by evidence of abnormal cerebral blood flow. RESULTS: Subjects were 48% DCI(+) and 52% DCI(-). DCI(+) subjects had more severe aSAH [HH (P = 0.002), Fisher (P = 0.004), admission Glasgow Coma Scale (P = 0.018)]. More DCI(+) subjects had pulmonary congestion than DCI(-) subjects (63 vs. 39%, P = 0.003). On echocardiogram, cardiac output (CO, liters per minute [LPM]) was significantly higher in DCI(+) than in DCI(-) subjects (6 ± 2 vs. 5 ± 1 LPM; P = 0.015). Multivariate analysis identified CO and Fisher grade as independent predictors of DCI (P = 0.02, 0.019). For each 1 LPM increase in CO, the odds of DCI increased by 1.5 (95% CI: 1.1-2.1). Fisher grade 4 increased the odds of DCI by 6.5 compared to Fisher grade 2 (95% CI: 1.6-25.8). After controlling for Fisher grade, CO remained an independent predictor of DCI (P = 0.02). Three-month mortality rate was not significantly different between DCI groups, P = 0.786. CONCLUSION: Elevated CO and Fisher grade are predictors of DCI after aSAH. However, prevention of DCI may not decrease mortality.
Authors: J Claassen; G L Bernardini; K Kreiter; J Bates; Y E Du; D Copeland; E S Connolly; S A Mayer Journal: Stroke Date: 2001-09 Impact factor: 7.914
Authors: J Michael Frangiskakis; Marilyn Hravnak; Elizabeth A Crago; Masaki Tanabe; Kevin E Kip; John Gorcsan; Michael B Horowitz; Amin B Kassam; Barry London Journal: Neurocrit Care Date: 2009-01-28 Impact factor: 3.210
Authors: Emmanuel Carrera; J Michael Schmidt; Mauro Oddo; Luis Fernandez; Jan Claassen; David Seder; Kiwon Lee; Neeraj Badjatia; E Sander Connolly; Stephan A Mayer Journal: Neurosurgery Date: 2009-08 Impact factor: 4.654
Authors: Jennifer A Frontera; Andres Fernandez; J Michael Schmidt; Jan Claassen; Katja E Wartenberg; Neeraj Badjatia; E Sander Connolly; Stephan A Mayer Journal: Stroke Date: 2009-04-09 Impact factor: 7.914
Authors: Marilyn Hravnak; J Michael Frangiskakis; Elizabeth A Crago; Yuefang Chang; Masaki Tanabe; John Gorcsan; Michael B Horowitz Journal: Stroke Date: 2009-08-27 Impact factor: 7.914
Authors: Emmanuel Carrera; J Michael Schmidt; Mauro Oddo; Noeleen Ostapkovich; Jan Claassen; Fred Rincon; David Seder; Errol Gordon; Pedro Kurtz; Kiwon Lee; E Sander Connolly; Neeraj Badjatia; Stephan A Mayer Journal: Cerebrovasc Dis Date: 2009-04-24 Impact factor: 2.762
Authors: I A C van der Bilt; D Hasan; W P Vandertop; A A M Wilde; A Algra; F C Visser; G J E Rinkel Journal: Neurology Date: 2009-02-17 Impact factor: 9.910
Authors: Mervyn D I Vergouwen; Nan van Geloven; Rob J de Haan; Nyika D Kruyt; Marinus Vermeulen; Yvo B W E M Roos Journal: Neurocrit Care Date: 2010-06 Impact factor: 3.210
Authors: Jan W Dankbaar; Mienke Rijsdijk; Irene C van der Schaaf; Birgitta K Velthuis; Marieke J H Wermer; Gabriel J E Rinkel Journal: Neuroradiology Date: 2009-07-22 Impact factor: 2.804
Authors: R P Killeen; A Gupta; H Delaney; C E Johnson; A J Tsiouris; J Comunale; M E Fink; H S Mangat; A Z Segal; A I Mushlin; P C Sanelli Journal: AJNR Am J Neuroradiol Date: 2013-11-07 Impact factor: 3.825
Authors: Elizabeth Crago; Kelly Kerris; Chien-Wen J Kuo; Paula Sherwood; Marilyn Hravnak; David Crippen; Michael Horowitz Journal: Am J Crit Care Date: 2014-01 Impact factor: 2.228
Authors: Wessel E van der Steen; Eva L Leemans; René van den Berg; Yvo B W E M Roos; Henk A Marquering; Dagmar Verbaan; Charles B L M Majoie Journal: Neuroradiology Date: 2019-01-28 Impact factor: 2.804
Authors: Khalil M Yousef; Jeffrey R Balzer; Catherine M Bender; Leslie A Hoffman; Samuel M Poloyac; Feifei Ye; Paula R Sherwood Journal: Am J Crit Care Date: 2015-07 Impact factor: 2.228